APA način citiranja (7. izdanje)

(15386826), Y. B., (15386829), S. Z., (15386832), X. Z., (15386835), Y. P., (15386838), Y. Y., (15386841), N. W., . . . (15386856), Y. W. (2025). Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.

Čikaški stil citiranja (17. izdanje)

(15386826), Yufang Bao, et al. Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition. 2025.

MLA način citiranja (9. izdanje)

(15386826), Yufang Bao, et al. Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition. 2025.